Research

Pharmaceutical Sciences

Title :

Molecular explorations of the Leishmania donovani Homoserine Dehydrogenase and evaluating the impact of its perturbations using CRISPR-Cas9 system’’

Area of research :

Pharmaceutical Sciences

Focus area :

Biotechnology, Molecular biology

Principal Investigator :

Dr. Sushma Singh, Associate Professor, National Institute of Pharmaceutical Education and Research (NIPER),

Timeline Start Year :

2023

Details

Executive Summary :

Understanding the biochemical pathways essential for parasite growth and survival can help develop novel therapeutics. The aspartate pathway, found in plants and bacterial strains, produces multiple amino acids like lysine, threonine, methionine, and isoleucine. The enzyme homoserine dehydrogenase (HSD) is essential for this pathway and is present in fungi, archaea, and gram-positive bacteria. The amnio acid threonine is crucial for the survival of trypanosomes and lipid biosynthesis. The CRISPR-Cas9 system can facilitate gene editing of HSD, which is more efficient than homologous recombination for genetic manipulation in Leishmania.

Total Budget (INR):

41,40,000

Organizations involved